Search clinical trials for: Investigation agent 2
Total 192048 results
-
Pusan National University HospitalUnknownTuberculosis | Lymphadenopathy | SarcoidosisKorea, Republic of
-
PfizerCompletedOsteoporosisUnited States, Norway, Brazil, Netherlands
-
University of CincinnatiMayfield Clinic & Spine InstituteCompletedTraumatic Brain Injury | Subarachnoid HemorrhageUnited States
-
Heilongjiang University of Chinese MedicineUnknownPolycystic Ovary SyndromeChina
-
Janssen Research & Development, LLCCompleted
-
Medical University of South CarolinaCompletedHyperglycemia | Diabetes | Kidney TransplantationUnited States
-
University Hospital, Basel, SwitzerlandCompletedRAS Peptide Profile in Healthy VolunteersSwitzerland
-
Weill Medical College of Cornell UniversityNational Institute of Neurological Disorders and Stroke (NINDS); University...Terminated
-
GlaxoSmithKlineCompleted
-
CIBA VISIONCompleted
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer
-
Jonsson Comprehensive Cancer CenterJanssen Scientific Affairs, LLCRecruitingProstate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8United States
-
National Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingExtensive Stage Lung Small Cell Carcinoma | Limited Stage Lung Small Cell Carcinoma | Platinum-Resistant Lung Small Cell Carcinoma | Platinum-Sensitive Lung Small Cell Carcinoma | Recurrent Lung Small Cell CarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI)RecruitingRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)Not yet recruitingProstate CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingDesmoplastic MelanomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingSoft Tissue Sarcoma | Leiomyosarcoma | Liposarcoma | Undifferentiated Pleomorphic Sarcoma | Soft Tissue Sarcoma of the Trunk and Extremities | Stage I Soft Tissue Sarcoma AJCC v7 | Stage II Soft Tissue Sarcoma AJCC v7 | Sarcoma G2 | Sarcoma G3United States, Canada
-
National Cancer Institute (NCI)WithdrawnUrothelial Carcinoma | Renal Pelvis and Ureter Urothelial Carcinoma | Bladder Carcinoma | Stage III Bladder Cancer AJCC v8 | Stage IVA Bladder Cancer AJCC v8 | Bladder Urothelial Carcinoma | Muscle Invasive Bladder Carcinoma | Stage II Bladder Cancer AJCC v8Canada
-
National Cancer Institute (NCI)CompletedUnresectable Hepatocellular Carcinoma | Advanced Adult Hepatocellular Carcinoma | Recurrent Hepatocellular Carcinoma | Stage IIIB Hepatocellular Carcinoma AJCC v7 | Stage IIIC Hepatocellular Carcinoma AJCC v7 | Stage IV Hepatocellular Carcinoma AJCC v7 | Stage III Hepatocellular Carcinoma AJCC v7 and other conditionsUnited States, Canada, Puerto Rico
-
Johns Hopkins All Children's HospitalTerminatedCentral Nervous System TumorsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Papillary Renal Cell Carcinoma | Hereditary Leiomyomatosis and Renal Cell Carcinoma | Sporadic Papillary Renal Cell CarcinomaUnited States
-
Baptist Health South FloridaBeiGeneRecruitingPrimary Central Nervous System Lymphoma | Relapsed Cancer | Refractory Cancer | Secondary Central Nervous System LymphomaUnited States
-
Erasmus Medical CenterRecruitingAutosomal Dominant Polycystic KidneyNetherlands
-
University of WashingtonNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Breast Adenocarcinoma | Invasive Breast Carcinoma of No Special TypeUnited States
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Type 1 Diabetes | Diabetic Kidney Disease | Endothelial Dysfunction | Insulin SensitivityUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Myelodysplastic Syndrome | Refractory Myelodysplastic Syndrome | Therapy-Related Myelodysplastic SyndromeUnited States
-
Taproot HealthRecruitingMelanoma | Sarcoma | Kidney Cancer | Adenocarcinoma | Renal Cell Carcinoma | Cervical Cancer | Acute Myeloid Leukemia | Stomach Cancer | Breast Cancer | Head and Neck Neoplasms | Nasopharyngeal Carcinoma | Glioblastoma | Astrocytoma | Multiple Myeloma | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel Cancer and other conditionsUnited States
-
Herlev and Gentofte HospitalDanish Society of CardiologyRecruitingDeep Vein Thrombosis | Pulmonary EmbolismDenmark
-
Imperial College LondonKing's College London; Medical University of Graz; University of Bordeaux; Hospital... and other collaboratorsActive, not recruitingAtrial Fibrillation | Intracerebral HemorrhageGermany, Spain, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated Carcinoma | Ovarian... and other conditionsUnited States, Canada, Singapore
-
Ono Pharmaceutical Co. LtdTerminatedMyelodysplastic Syndromes | Acute LeukemiaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell Lymphoma | CD20 Positive | Refractory Mantle Cell Lymphoma | Blastoid Variant Mantle Cell Lymphoma | CCND1 Protein Overexpression | CD5 Positive | FCER2 Negative | Pleomorphic Variant Mantle Cell Lymphoma | t(11;14)(q13;q32)United States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Metastatic Pancreatic Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Advanced Pancreatic Adenocarcinoma | Platinum-Resistant... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyWithdrawnMetastatic Uveal Melanoma | Advanced Uveal Melanoma | Unresectable Uveal Melanoma
-
University of Nevada, Las VegasCompletedHypertensionUnited States
-
Cancer Hospital of Guangxi Medical UniversityActive, not recruitingTACE | Lenvatinib | Tislelizumab | Advanced Unresectable Hepatocellular CarcinomaChina
-
AMAG Pharmaceuticals, Inc.ResearchPoint GlobalCompletedPreterm BirthUnited States, Spain, Russian Federation, Canada, Bulgaria, Czechia, Hungary, Italy, Ukraine
-
SanofiCompleted
-
Dow University of Health SciencesCompletedDental Pulp DiseasesPakistan
-
Organon and CoCompletedBenign Prostatic Hyperplasia
-
Baxalta now part of ShireBaxter Healthcare, Ltd. (New Zealand), Baxter Healthcare Pty. Ltd. (Australia)CompletedAlpha 1-Antitrypsin DeficiencyAustralia, New Zealand
-
Ain Shams UniversityCompletedPreterm Premature Rupture of MembraneEgypt
-
Galera Therapeutics, Inc.Completed
-
University of PisaCompleted
-
University of Lausanne HospitalsCompletedIntradermal (ID) Vaccination Device
-
Prevention Strategies, LLCCompletedAlcohol Drinking | Harm Reduction | Social Norms | Expectations
-
Medical University of ViennaCompletedVaccine Responsiveness in Allergy | Vaccine Responsiveness During Allergy De-sensitization TreatmentAustria